OverviewSuggest Edit

Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy. Additionally, it offers antibody therapeutics based on its proprietary immunotherapy technology.
TypePublic
Founded2015
HQKR
Websiteeutilex.com

Locations

Eutilex is headquartered in
Korea (Republic of)

Location Map

Latest Updates

Share Price (Jan 2021)₩52.1 K(-6%)
Cybersecurity ratingBMore

Key People/Management at Eutilex

Byoung S. Kwon

Byoung S. Kwon

CEO
Soo Young Choi

Soo Young Choi

COO
Hoon-Sung Jeh

Hoon-Sung Jeh

CTO
Edwin E. Kwon

Edwin E. Kwon

CFO
Jeonghoon Han

Jeonghoon Han

CBO
Young Ho Kim

Young Ho Kim

CDO
Show more

Eutilex Office Locations

Eutilex has an office in
Show all (1)

Eutilex Financials and Metrics

Eutilex Revenue

Market capitalization (15-Jan-2021)

379.8b

Closing stock price (15-Jan-2021)

52.1k
Eutilex's current market capitalization is ₩379.8 b.
Show all financial metrics

Eutilex Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Eutilex Online and Social Media Presence

Embed Graph

Eutilex Frequently Asked Questions

  • When was Eutilex founded?

    Eutilex was founded in 2015.

  • Who are Eutilex key executives?

    Eutilex's key executives are Byoung S. Kwon, Soo Young Choi and Hoon-Sung Jeh.

  • Who are Eutilex competitors?

    Competitors of Eutilex include Alpha Tau Medical, Foghorn Therapeutics and Gossamer Bio.

  • Where are Eutilex offices?

    Eutilex has an office in.

  • How many offices does Eutilex have?

    Eutilex has 1 office.